CELU Celularity Inc
AI brief AI-written, not reviewed by a person
Latest period figures show a 12-month revenue of 26,550,000 USD and a net loss of 91,716,000 USD for the year ended 2025-12-31, with quarterly figures indicating continued negative operating income and a small positive quarterly net income in 2026-Q2. Total assets at 2026-06-30 were 96,167,000 USD and total liabilities were 131,698,000 USD. Stockholders’ equity remains negative at -35,531,000 USD for 2026-06-30, reflecting ongoing deficit dynamics.
- Revenue (year) for 12 months to 2025-12-31: 26,550,000 USD, compared with 54,220,000 USD for 12 months to 2024-12-31, indicating a decline year over year. [1][2]
- Net income (year) for 12 months to 2025-12-31: -91,716,000 USD, compared with -57,892,000 USD for 12 months to 2024-12-31, indicating a larger annual net loss year over year. [1][2]
- Diluted EPS (year) 12 months to 2025-12-31: -3.59 USD/shares, vs -2.64 USD/shares for 2024-12-31. [1][2]
- Total assets at 2026-06-30: 96,167,000 USD; Total liabilities at 2026-06-30: 131,698,000 USD; Stockholders’ equity at 2026-06-30: -35,531,000 USD. [1][2][3]
- Shares outstanding at 2026-09-30: 32,449,891 shares (latest listed), indicating potential share count implications for per-share metrics. [1]
- Quarterly net income (quarter) for 3 months to 2026-06-30: 706,000 USD, representing a positive quarterly result after previous negatives. [1][2]
- Quarterly revenue (quarter) for 3 months to 2026-06-30: 5,432,000 USD. [1]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
What the sources did not support
- No data provided for cash and equivalents at period end other than 2026-06-30 and 2025-12-31; no reconciliation details.
- No explicit comparison figures for 2026-03-31 or 2025-09-30 year-to-date figures beyond those in the sources.
- No forward-looking statements or market context beyond filing numbers.
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Revenue (quarter) (3 months to 2026-06-30) | 5,432,000 USD | sec-companyfacts | current | ||
| Revenue (year) (12 months to 2025-12-31) | 26,550,000 USD | sec-companyfacts | current | ||
| Net income (quarter) (3 months to 2026-06-30) | 706,000 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2025-12-31) | -91,716,000 USD | sec-companyfacts | current | ||
| Operating income (quarter) (3 months to 2026-06-30) | -4,237,000 USD | sec-companyfacts | current | ||
| Operating income (year) (12 months to 2025-12-31) | -61,308,000 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-06-30) | 0.02 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2025-12-31) | -3.59 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2026-03-31) | 1,447,000 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2025-12-31) | -13,254,000 USD | sec-companyfacts | current | ||
| Total assets (at 2026-06-30) | 96,167,000 USD | sec-companyfacts | current | ||
| Total liabilities (at 2026-06-30) | 131,698,000 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-06-30) | -35,531,000 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2026-06-30) | 586,000 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2026-09-30) | 32,449,891 shares | sec-companyfacts | current |
Context
No reviewed context has been published for CELU. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add CELU to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: CELU.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.